Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-18 Sale | 2023-09-19 5:05 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $45 | $56,250 | 781,870 (Indirect Direct) | View |
| 2023-09-18 Sale | 2023-09-19 5:03 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 20,350 | $44.27 | $900,813 | 168,565 (Direct) | View |
| 2023-09-15 Sale | 2023-09-18 4:24 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $45.34 | $56,675 | 783,120 (Indirect Direct) | View |
| 2023-09-08 Sale | 2023-09-11 4:58 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $42.87 | $514,440 | 1,095,807 (Direct) | View |
| 2023-09-06 Sale | 2023-09-07 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer | 1,756 | $43.01 | $75,526 | 68,299 (Direct) | View |
| 2023-08-31 Sale | 2023-09-01 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 551 | $41.23 | $22,716 | 30,312 (Direct) | View |
| 2023-09-01 Sale | 2023-09-01 4:05 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 150,000 | $41.75 | $6,262,959 | 1,996,223 (Indirect Direct) | View |
| 2023-08-08 Sale | 2023-08-09 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $23.66 | $283,920 | 1,107,807 (Direct) | View |
| 2023-07-17 Sale | 2023-07-18 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $64.79 | $80,988 | 784,370 (Indirect Direct) | View |
| 2023-07-10 Sale | 2023-07-11 5:37 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $84.55 | $1,014,600 | 1,119,807 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 4:20 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 8,510 | $89.98 | $765,730 | 176,458 (Indirect Direct) | View |
| 2023-07-03 Sale | 2023-07-06 4:16 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,779 | $89.97 | $609,928 | 416,006 (Indirect Direct) | View |
| 2023-06-20 Sale | 2023-06-21 4:34 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $88.41 | $110,513 | 785,620 (Indirect Direct) | View |
| 2023-06-08 Sale | 2023-06-09 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $91.35 | $1,096,200 | 1,131,807 (Direct) | View |
| 2023-06-05 Sale | 2023-06-06 4:59 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 69,779 | $88.8 | $6,196,527 | 422,785 (Indirect Direct) | View |
| 2023-06-01 Sale | 2023-06-02 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $86 | $430,000 | 147,504 (Direct) | View |
| 2023-05-17 Sale | 2023-05-18 5:12 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $88.66 | $110,825 | 786,870 (Indirect Direct) | View |
| 2023-05-16 Sale | 2023-05-18 5:10 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 30,000 | $85.66 | $2,569,900 | 2,466,223 (Indirect Direct) | View |
| 2023-05-08 Sale | 2023-05-09 5:02 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $92.39 | $1,108,680 | 1,143,807 (Direct) | View |
| 2023-05-03 Sale | 2023-05-04 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $82.71 | $413,550 | 358,495 (Direct) | View |
| 2023-04-18 Sale | 2023-04-20 4:51 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 30,000 | $82.02 | $2,460,720 | 2,546,223 (Indirect Direct) | View |
| 2023-04-17 Sale | 2023-04-18 4:30 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $81.05 | $101,313 | 788,120 (Indirect Direct) | View |
| 2023-04-10 Sale | 2023-04-11 4:20 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $78.21 | $938,520 | 1,155,807 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:54 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 500 | $74.05 | $37,025 | 403,831 (Indirect Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:52 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $75 | $375,000 | 152,430 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:50 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $74.05 | $370,250 | 363,495 (Direct) | View |
| 2023-03-21 Sale | 2023-03-23 4:55 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 30,000 | $62.74 | $1,882,332 | 2,958,842 (Indirect Direct) | View |
| 2023-03-17 Sale | 2023-03-21 4:35 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $64.03 | $80,038 | 789,370 (Indirect Direct) | View |
| 2023-03-08 Sale | 2023-03-10 5:18 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $63.79 | $765,480 | 1,167,807 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-19 Gift | 2023-09-20 4:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 150,000 | $0 | 1,996,223 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 781,870 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:05 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 781,870 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:03 pm | N/A 2030-08-16 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 9,719 | $0 | 168,565 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 9,719 | $29.76 | 168,565 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 4:24 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 783,120 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 4:24 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 783,120 (Direct) | View |
| 2023-09-14 Option Award | 2023-09-18 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 2,500 | $0 | 32,812 (Direct) | View |
| 2023-09-08 Exercise | 2023-09-11 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,095,807 (Direct) | View |
| 2023-09-08 Exercise | 2023-09-11 4:58 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,095,807 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-01 4:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 300,000 | $2.67 | 1,996,223 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-01 4:05 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 300,000 | $0 | 1,996,223 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-09 4:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,107,807 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-09 4:08 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,107,807 (Direct) | View |
| 2023-07-21 Exercise | 2023-07-24 5:01 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 49,779 | $2.67 | 784,370 (Direct) | View |
| 2023-07-21 Exercise | 2023-07-24 5:01 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 49,779 | $0 | 784,370 (Direct) | View |
| 2023-07-20 Exercise | 2023-07-21 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 50,000 | $2.67 | 784,370 (Direct) | View |
| 2023-07-20 Exercise | 2023-07-21 4:13 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 50,000 | $0 | 784,370 (Direct) | View |
| 2023-07-17 Exercise | 2023-07-18 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 784,370 (Direct) | View |
| 2023-07-17 Exercise | 2023-07-18 4:40 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 784,370 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 5:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,119,807 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 5:37 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,119,807 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 4:16 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,779 | $0 | 416,006 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 4:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,779 | $10.03 | 416,006 (Direct) | View |
| 2023-06-28 Gift | 2023-06-29 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 12,750 | $0 | 184,968 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 785,620 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:34 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 785,620 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-09 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,131,807 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-09 4:40 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,131,807 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:59 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 69,779 | $0 | 422,785 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:59 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 69,779 | $10.03 | 422,785 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $34.11 | 147,504 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 4:40 pm | N/A 2030-05-03 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $0 | 147,504 (Direct) | View |
| 2023-05-24 Gift | 2023-05-25 4:44 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 20,000 | $0 | 1,846,223 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-18 5:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 786,870 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-18 5:12 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 786,870 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 5:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 50,000 | $2.67 | 2,466,223 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 5:10 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 50,000 | $0 | 2,466,223 (Direct) | View |
| 2023-05-08 Exercise | 2023-05-09 5:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,143,807 (Direct) | View |
| 2023-05-08 Exercise | 2023-05-09 5:02 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,143,807 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-04 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 358,495 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-04 4:40 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 358,495 (Direct) | View |
| 2023-05-03 Gift | 2023-05-03 4:22 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 20,000 | $0 | 133,945 (Direct) | View |
| 2023-04-27 Gift | 2023-04-28 4:15 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 382,946 | $0 | 1,826,223 (Direct) | View |
| 2023-04-21 Gift | 2023-04-24 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 67,955 | $0 | 184,968 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-20 4:51 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 50,000 | $2.67 | 2,546,223 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-20 4:51 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 50,000 | $0 | 2,546,223 (Direct) | View |
| 2023-04-19 Gift | 2023-04-20 4:15 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 36,232 | $0 | 133,945 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 4:30 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 788,120 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 4:30 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 788,120 (Direct) | View |
| 2023-04-10 Exercise | 2023-04-11 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,155,807 (Direct) | View |
| 2023-04-10 Exercise | 2023-04-11 4:20 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,155,807 (Direct) | View |
| 2023-04-03 Gift | 2023-04-05 5:56 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 634,211 | $0 | 1,806,223 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:52 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $34.11 | 152,430 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:52 pm | N/A 2030-05-03 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $0 | 152,430 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:50 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 363,495 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:50 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 363,495 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 4:55 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 50,000 | $2.67 | 2,958,842 (Direct) | View |
| 2023-03-22 Exercise | 2023-03-23 4:55 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 7,221 | $13.85 | 2,958,842 (Direct) | View |
| 2023-03-22 Exercise | 2023-03-23 4:55 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 100,000 | $3.76 | 2,958,842 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 4:55 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 157,221 | $0 | 2,958,842 (Direct) | View |
| 2023-03-17 Exercise | 2023-03-21 4:35 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 789,370 (Direct) | View |
| 2023-03-17 Exercise | 2023-03-21 4:35 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 789,370 (Direct) | View |
| 2023-03-08 Exercise | 2023-03-10 5:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,167,807 (Direct) | View |
| 2023-03-08 Exercise | 2023-03-10 5:18 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,167,807 (Direct) | View |